562 results on '"Yonan N"'
Search Results
2. National Healthcare Delivery Systems Influence Lung Transplant Outcomes for Cystic Fibrosis
3. Isolation of Aspergillus species from the airway of lung transplant recipients is associated with excess mortality
4. Performance League Tables
5. HMG-CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation
6. Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance
7. Potential immunologic effects of statins in cancer following transplantation
8. Does CMV Status Affect Morbidity and Survival Following Heart Transplantation? A Large Multicentre Retrospective Study
9. Second Line Options for Hyperlipidemia Management after Cardiac Transplantation
10. Cyclosporine Profiling With C 2 and C 0 Monitoring Improves Outcomes After Heart Transplantation
11. Management after lung transplant
12. Does CMV Status Impact on Morbidity and Survival Following Heart Transplantation? A Large Multi-Centre Retrospective UK Study
13. Angiotensin converting enzyme insertion/deletion polymorphism does not influence postcardiac transplantation hypertension onset or progression
14. The Effects of ACE Inhibition on Serum Angiotensin II Concentration Following Cardiac Transplantation
15. CD4−veCD8−ve CD30+ve T Cells Are Detectable in Human Lung Transplant Patients and Their Proportion of the Lymphocyte Population After In Vitro Stimulation With Donor Spleen Cells Correlates With Preservation of Lung Physiology
16. Donor CCR5 Δ32 Polymorphism and Outcome Following Cardiac Transplantation
17. Irish Thoracic Society: Proceedings of Annual Scientific Meeting held in Dublin on 4th & 5th November, 1994
18. Superior Prevention of Acute Rejection by Tacrolimus vs. Cyclosporine in Heart Transplant Recipients—A Large European Trial
19. The distribution of cardiac macrophages in myocardial ischaemia and cardiomyopathy
20. Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease
21. A novel polymorphism of the gene encoding furin, a TGF-β1 activator, and the influence on cardiac allograft vasculopathy formation
22. The influence of donor age on transplant coronary artery disease and survival post heart transplantation: Is it safe to extend donor age?
23. The donor CCR5 Ä32 polymorphism and outcome following cardiac transplantation: 17.3
24. Performance league tables : Publication of league tables needs to be open and accurate
25. Tumour necrosis factor α gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction?
26. Influence of interleukin-10 polymorphism on the development of coronary vasculopathy following cardiac transplantation
27. INTERLEUKIN-10 GENOTYPE IN CARDIOMYOPATHY AND ISCHAEMIC HEART DISEASE.
28. Value of echocardiography in predicting long term outcome after heart transplantation
29. Epstein-Barr virus associated graft failure following heart/lung transplantation
30. USE OF CHEST X-RAY (CXR) AFTER BIOPSY OF THE TRANSPLANTED HEART
31. Atrial arrhythmias and pacing after orthotopic heart transplantation: bicaval versus standard atrial anastomosis
32. Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients
33. Influence of tumor necrosis factor-α gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation
34. Transforming growth factor-beta: association with arteriosclerosis and left ventricular dysfunction after heart transplantation
35. Polymorphism of the transforming growth factor–beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation
36. Heart transplantation for peripartum cardiomyopathy: a report of three cases and a literature review
37. The development of a quantitative PCR ELISA to determine HCMV DNAaemia levels in heart, heart/lung and lung transplant recipients
38. Orthotropic heart transplantation for rare indications: A single centre experience
39. Predictors of Survival in Patients Undergoing VA-ECMO and the Utility of the SAVE Score in a UK Transplant Population
40. Early CMV Management Post Lung Transplant(LTx): A 6-Year Review of Pre-Emptive Strategy for CMV
41. Outcomes and Characteristics of Patients with Critical Cardiogenic Shock Admitted to a Quaternary Heart Failure Unit in the UK
42. C-Reactive Protein (CRP) Correlates Poorly with Infection in the Post-Surgical Period Following Left Ventricular Assist Device (LVAD) Implantation
43. Predictors of Survival in Critical Cardiogenic Shock Admissions to a Quaternary Heart Failure Unit in the UK
44. Donor Heart Selection: Wythenshawe Experience
45. A Study of Donor Ex-Vivo Lung Perfusion in UK Lung Transplantation (DEVELOP-UK)
46. Outcome of CentriMag Extracorporeal Mechanical Circulatory Support Use in Critical Cardiogenic Shock (INTERMACS 1) Patients
47. Profiling Biomarkers of Inflammation and Tissue Injury during Human Ex Vivo Lung Perfusion in the DEVELOP-UK Study
48. Validation of the endothelial staining markers CD31 and CD34 in immunohistochemistry of the long saphenous vein.
49. Ultrastructural Changes in Epithelial and Endothelial Barriers During Ex-Vivo Lung Perfusion
50. CentriMag Short Term Ventricular Assist Device as a Bridge to Decision in Critical Cardiogenic Shock (INTERMACS 1) - The Manchester Experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.